韩国 2019 冠状病毒病（COVID-19）实验室诊断指南。
Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea.
机构信息
Department of Laboratory Medicine, Seoul Medical Center, Seoul, Korea.
Center for Laboratory Control of Infectious Diseases, Centers for Disease Control and Prevention, Osong, Korea.
出版信息
Ann Lab Med. 2020 Sep;40(5):351-360. doi: 10.3343/alm.2020.40.5.351.
Abstract
The outbreak of coronavirus disease 2019 (COVID-19), which began in December 2019, is still ongoing in Korea, with >9,000 confirmed cases as of March 25, 2020. COVID-19 is a severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infection, and real-time reverse transcription-PCR is currently the most reliable diagnostic method for COVID-19 around the world. Korean Society for Laboratory Medicine and the Korea Centers for Disease Prevention and Control propose guidelines for diagnosing COVID-19 in clinical laboratories in Korea. These guidelines are based on other related domestic and international guidelines, as well as expert opinions and include the selection of test subjects, selection of specimens, diagnostic methods, interpretation of test results, and biosafety.
摘要
2019 年 12 月开始的 2019 年冠状病毒病（COVID-19）疫情仍在韩国持续，截至 2020 年 3 月 25 日，已确诊超过 9000 例。COVID-19 是一种严重急性呼吸系统综合征冠状病毒 2（SARS-CoV-2）感染，实时逆转录-聚合酶链反应（RT-PCR）是目前全球 COVID-19 最可靠的诊断方法。韩国临床检验医学会和韩国疾病预防控制中心提出了韩国临床实验室诊断 COVID-19 的指南。这些指南是基于其他相关的国内外指南、专家意见，包括检测对象的选择、标本的选择、诊断方法、检测结果的解释以及生物安全。
相似文献
1
Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea.韩国 2019 冠状病毒病（COVID-19）实验室诊断指南。
Ann Lab Med. 2020 Sep;40(5):351-360. doi: 10.3343/alm.2020.40.5.351.
2
Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories.印度针对 SARS-CoV-2 检测的实验室准备：利用病毒研究和诊断实验室网络。
Indian J Med Res. 2020;151(2 & 3):216-225. doi: 10.4103/ijmr.IJMR_594_20.
3
COVID-19 Molecular Testing in Korea: Practical Essentials and Answers From Experts Based on Experiences of Emergency Use Authorization Assays.韩国的 COVID-19 分子检测：基于紧急使用授权检测经验的专家实用要点和解答
Ann Lab Med. 2020 Nov;40(6):439-447. doi: 10.3343/alm.2020.40.6.439. Epub 2020 Jun 17.
4
Pooling Upper Respiratory Specimens for Rapid Mass Screening of COVID-19 by Real-Time RT-PCR.实时 RT-PCR 对呼吸道样本进行快速批量筛查 COVID-19。
Emerg Infect Dis. 2020 Oct;26(10):2469-2472. doi: 10.3201/eid2610.201955. Epub 2020 Aug 26.
5
The diagnostic methods in the COVID-19 pandemic, today and in the future.新冠疫情时期及未来的诊断方法。
Expert Rev Mol Diagn. 2020 Sep;20(9):985-993. doi: 10.1080/14737159.2020.1816171. Epub 2020 Sep 16.
6
Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated and with Clinical Specimens.新型高灵敏度和特异性 COVID-19-RdRp/Hel 实时荧光 RT-PCR 检测方法在临床标本中的验证及对 COVID-19 的分子诊断改良
J Clin Microbiol. 2020 Apr 23;58(5). doi: 10.1128/JCM.00310-20.
7
Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion.利用 Panther Fusion 的公开访问协议，快速随机检测新型 SARS-CoV-2（以前称为 2019-nCoV）。
J Clin Virol. 2020 Apr;125:104305. doi: 10.1016/j.jcv.2020.104305. Epub 2020 Feb 28.
8
Laboratory Diagnosis of COVID-19: Current Issues and Challenges.新型冠状病毒肺炎的实验室诊断：当前的问题和挑战。
J Clin Microbiol. 2020 May 26;58(6). doi: 10.1128/JCM.00512-20.
9
[Diagnostic consideration and bedside estimation of the prognosis in COVID-19 patients].[新型冠状病毒肺炎患者的诊断考量与床旁预后评估]
Orv Hetil. 2020 Apr 1;161(17):667-671. doi: 10.1556/650.2020.31815.
10
Surveillance of Coronavirus Disease 2019 (COVID-19) Testing in Clinical Laboratories in Korea.韩国临床实验室 2019 冠状病毒病（COVID-19）检测监测。
Ann Lab Med. 2021 Mar 1;41(2):225-229. doi: 10.3343/alm.2021.41.2.225.
引用本文的文献
1
Optimal Timing for Expanding Diagnostic Laboratories, South Korea.韩国扩大诊断实验室的最佳时机
Emerg Infect Dis. 2025 Aug;31(8):1-8. doi: 10.3201/eid3108.241745.
2
A Proactive Testing Strategy to COVID-19 for Reopening University Campus during Omicron Wave in Korea: Ewha Safe Campus (ESC) Project.韩国奥密克戎浪潮期间为大学校园重新开放制定的新冠病毒主动检测策略：梨花女子大学安全校园（ESC）项目
Ewha Med J. 2023 Jul;46(3):e7. doi: 10.12771/emj.2023.e7. Epub 2023 Jul 31.
3
Verification of the Performance of the Panbio COVID-19 Ag Rapid Test Device for Implementation in the Clinical Laboratory.用于临床实验室实施的Panbio新冠病毒抗原快速检测设备性能验证
Ewha Med J. 2023 Jan;46(1):e2. doi: 10.12771/emj.2023.e2. Epub 2023 Jan 31.
4
Sex and other predictors of mortality in long-term follow-up of patients with cardiovascular disease and COVID-19: a single-center retrospective study.心血管疾病合并 COVID-19 患者长期随访中死亡的性别及其他预测因素：一项单中心回顾性研究
Sci Rep. 2025 Apr 17;15(1):13245. doi: 10.1038/s41598-025-93402-w.
5
Role of and polymorphisms in clinical severity and outcomes of COVID-19 in Egypt.埃及COVID-19临床严重程度和结局中[具体基因名称]和[具体基因名称]多态性的作用。 （注：原文中两个“and”前缺少具体基因相关内容，这里用[具体基因名称]替代以便更完整表达意思）
Afr J Lab Med. 2024 Aug 27;13(1):2375. doi: 10.4102/ajlm.v13i1.2375. eCollection 2024.
6
Prevalence of SARS-CoV-2 virus in saliva, stool, and urine samples of COVID-19 patients in Bihar, India.印度比哈尔邦新冠肺炎患者唾液、粪便和尿液样本中SARS-CoV-2病毒的流行情况。
Access Microbiol. 2024 Jun 14;6(6). doi: 10.1099/acmi.0.000693.v4. eCollection 2024.
7
RT-qPCR investigation of post-mortem tissues during COVID-19.针对 COVID-19 死后组织的 RT-qPCR 研究。
J Appl Biomed. 2024 Jun;22(2):115-122. doi: 10.32725/jab.2024.013. Epub 2024 Jun 21.
8
COVID-19 in the Arab countries: Three-year study.阿拉伯国家的 COVID-19：三年研究。
F1000Res. 2024 May 29;12:1448. doi: 10.12688/f1000research.142541.3. eCollection 2023.
9
Realistic Estimation of COVID-19 Infection by Seroprevalence Surveillance of SARS-CoV-2 Antibodies: An Experience From Korea Metropolitan Area From January to May 2022.通过SARS-CoV-2抗体血清流行率监测对COVID-19感染情况的实际估计：来自韩国首都地区2022年1月至5月的经验
J Korean Med Sci. 2024 Feb 5;39(5):e43. doi: 10.3346/jkms.2024.39.e43.
10
The impact of preoperative coronavirus disease 19 infection on early postoperative mortality during the vaccination era: a nationwide retrospective cohort study.接种时代术前新型冠状病毒肺炎感染对术后早期死亡率的影响：一项全国性回顾性队列研究。
Korean J Anesthesiol. 2024 Apr;77(2):185-194. doi: 10.4097/kja.23761. Epub 2024 Jan 26.
本文引用的文献
1
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒：将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.
2
SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.感染患者上呼吸道标本中的新型冠状病毒2型病毒载量
N Engl J Med. 2020 Mar 19;382(12):1177-1179. doi: 10.1056/NEJMc2001737. Epub 2020 Feb 19.
3
Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia.新型冠状病毒（2019-nCoV）引起肺炎爆发的分子诊断。
Clin Chem. 2020 Apr 1;66(4):549-555. doi: 10.1093/clinchem/hvaa029.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
6
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.实时 RT-PCR 检测 2019 新型冠状病毒（2019-nCoV）
Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000045.
7
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
8
Korean Society for Laboratory Medicine Practice Guidelines for the Molecular Diagnosis of Middle East Respiratory Syndrome During an Outbreak in Korea in 2015.韩国检验医学学会《2015年韩国中东呼吸综合征疫情期间分子诊断实践指南》
Ann Lab Med. 2016 May;36(3):203-8. doi: 10.3343/alm.2016.36.3.203.
9
A pancoronavirus RT-PCR assay for detection of all known coronaviruses.一种用于检测所有已知冠状病毒的泛冠状病毒逆转录聚合酶链反应检测法。
Methods Mol Biol. 2008;454:3-12. doi: 10.1007/978-1-59745-181-9_1.
Zotero 插件